- Home
- ZCMD vs CGTX Comparison
ZCMD vs CGTX Comparison
Compare ZCMD & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZCMD
- CGTX
- Stock Information
- Founded
- ZCMD 2012
- CGTX 2007
- Country
- ZCMD China
- CGTX United States
- Employees
- ZCMD N/A
- CGTX N/A
- Industry
- ZCMD Other Consumer Services
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- ZCMD Real Estate
- CGTX Health Care
- Exchange
- ZCMD Nasdaq
- CGTX Nasdaq
- Market Cap
- ZCMD 29.0M
- CGTX 25.1M
- IPO Year
- ZCMD 2020
- CGTX 2021
- Fundamental
- Price
- ZCMD $1.16
- CGTX $0.57
- Analyst Decision
- ZCMD
- CGTX Strong Buy
- Analyst Count
- ZCMD 0
- CGTX 4
- Target Price
- ZCMD N/A
- CGTX $2.83
- AVG Volume (30 Days)
- ZCMD 597.6K
- CGTX 16.9M
- Earning Date
- ZCMD 01-01-0001
- CGTX 08-07-2025
- Dividend Yield
- ZCMD N/A
- CGTX N/A
- EPS Growth
- ZCMD N/A
- CGTX N/A
- EPS
- ZCMD N/A
- CGTX N/A
- Revenue
- ZCMD $15,864,773.00
- CGTX N/A
- Revenue This Year
- ZCMD N/A
- CGTX N/A
- Revenue Next Year
- ZCMD N/A
- CGTX N/A
- P/E Ratio
- ZCMD N/A
- CGTX N/A
- Revenue Growth
- ZCMD N/A
- CGTX N/A
- 52 Week Low
- ZCMD $0.95
- CGTX $0.22
- 52 Week High
- ZCMD $2.97
- CGTX $2.54
- Technical
- Relative Strength Index (RSI)
- ZCMD 46.90
- CGTX 63.33
- Support Level
- ZCMD $1.12
- CGTX $0.52
- Resistance Level
- ZCMD $1.24
- CGTX $1.04
- Average True Range (ATR)
- ZCMD 0.13
- CGTX 0.09
- MACD
- ZCMD -0.01
- CGTX 0.04
- Stochastic Oscillator
- ZCMD 16.03
- CGTX 40.18
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.